Comprehensive analysis of the prognosis and immune effect of the oncogenic protein Four Jointed Box 1
pubmed: wnt1 2023-09-30
Summary:
CONCLUSION: Our research findings demonstrate that FJX1 is a new prognostic factor with a significant role in tumor immunity. Our results highlight the importance of further exploring the potential of targeting FJX1 as a therapeutic strategy in cancer.